Kuznetsov Sergey
Senior Scientist
Beskrivning
Nyckelord
breast cancer, Rad51c, BRCA1, GPRC5A, HTS
Affiliering
Institute for Molecular Medicine Finland
Senior Scientist
Primär
High Throughput Biomedicine Unit
2018 - nuvarande
Primär
Källa: ORCID
University of Helsinki
FIMM-EMBL Group Leader
Institute for Molecular Medicine Finland (FIMM)
2008 - 2016
Källa: ORCID
National Cancer Institute, NIH
post-doc
Mouse Cancer Genetics Program
2002 - 2008
Källa: ORCID
Utbildning (3)
PhD
1998 - 2002
University of Kiel
MSc
1995 - 1997
St. Petersburg State University
BSc
1990 - 1995
St. Petersburg State University
Publikationer (29)
2023
Nucleic Acids Research
Öppen tillgång
Referentgranskad
2021
Öppen tillgång
Referentgranskad
2019
The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
Beviljade finansiering (4)
Developing personalized therapeutic approaches for BRCA1-mutated breast cancers
Cancer Society of Finland
2011 - 2012
2011 - 2016
Identifying New Therapeutic Targets for Hereditary Breast Cancers
Finlands Akademi
2011 - 2016
IDENTIFYING NEW THERAPEUTIC TARGETS FOR HEREDITARY BREAST CANCERS
Finlands Akademi
2011 - 2016
Aktiviteter och priser (1)
Annan aktivitet
Functional Analysis of Human BRCA2 Variants Using a Mouse Embryonic Stem Cell-Based Assay
2010
International collaboration: Nej